Earlier this month, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) reclassified certain glucosamine products as medicines. According to the MHRA statement, products containing doses equal to or greater than 1178 mg per day of base glucosamine (equivalent to 1500 mg glucosamine sulphate) can no longer be classified as food supplements and are now medicines. This reclassification was based on the evidence of pharmacological effects as well as the intended use of consumers. Glucosamine-containing products are currently being used to alleviate joint problems – a medicinal purpose.
This MHRA decision will affect most of the current food supplements on the market. All food supplements containing doses of glucosamine of at least 1178 mg per day will now need a marketing authorization. Alternatively, reformulation of the product is necessary. If you need support with your glucosamine-containing product, please get in touch.